Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oligometastatic Non-small Cell Lung Cancer (NSCLC)”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Not applicableUnknownNCT05647590
What this trial is testing

SBRT/RT in Oligometastatic Stage IV NSCLC

Who this might be right for
Non Small Cell Lung Cancer
University Hospital Ostrava 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT03808662
What this trial is testing

Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

Who this might be right for
TNBC - Triple-Negative Breast CancerTriple Negative Breast CancerNSCLC+4 more
Memorial Sloan Kettering Cancer Center 107
Early research (Phase 1)Ended earlyNCT03275597
What this trial is testing

Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Non-small Lung Cancer (NSCLC) With Dual Immune Checkpoint Inhibition

Who this might be right for
Non-small Cell Lung CancerNon-small Cell Lung Cancer Stage IV
University of Wisconsin, Madison 17
Testing effectiveness (Phase 2)UnknownNCT05055583
What this trial is testing

Toripalimab in Combination With Platinum-based Chemotherapy for Mutation-negative Stage IV Oligometastatic NSCLC

Who this might be right for
NSCLC Stage IVOligometastasis
Tang-Du Hospital 30
Not applicableNot Yet RecruitingNCT07462728
What this trial is testing

Phase III, Multicenter, Randomized Controlled Clinical Study of Three-Dimensional Radiotherapy for Primary Tumors in Non-Oligometastatic Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer MetastaticRadiotherapy
Guizhou Medical University 200
Testing effectiveness (Phase 2)Ended earlyNCT05846646
What this trial is testing

Study of PULSAR-ICI +/- IMSA101 in Patients With Oligometastatic NSCLC and RCC

Who this might be right for
Oligometastatic Disease
ImmuneSensor Therapeutics Inc. 6
Testing effectiveness (Phase 2)UnknownNCT03557411
What this trial is testing

A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Hypofraction Radiotherapy in Patients With NSCLC

Who this might be right for
Non-Small-Cell Lung Cancer
Shandong Cancer Hospital and Institute 42
Large-scale testing (Phase 3)UnknownNCT02076477
What this trial is testing

The Optimal Intervention Time of Radiotherapy for Oligometastatic Stage IV Non-small Cell Lung Cancer(NSCLC)

Who this might be right for
Oligo-metastatic Stage IV Non-small Cell Lung Cancer
Sichuan Cancer Hospital and Research Institute 420
Not applicableUnknownNCT05176067
What this trial is testing

Randomized Controlled Clinical Study of Drug Therapy Combined With Thoracic Radiotherapy for Non-oligometastatic NSCLC

Who this might be right for
Stage IV Non-small Cell Lung Cancer
Guizhou Medical University 88
Not applicableStudy completedNCT02450591
What this trial is testing

Local Therapies for Oligometastatic Non-Small Cell Lung Cancer Harboring Sensitizing EGFR Mutations

Who this might be right for
Oligometastatic Lung Adenocarcinoma
Memorial Sloan Kettering Cancer Center 4
Testing effectiveness (Phase 2)UnknownNCT02975609
What this trial is testing

Phase II Trial of SBRT Compared With Conventional Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer

Who this might be right for
NSCLC
Shanghai Chest Hospital 100
Large-scale testing (Phase 3)Looking for participantsNCT06840782
What this trial is testing

First-line Immunotherapy-based Standard of Care and Local Ablative Treatments for Oligometastatic Non-small Cell Lung Cancer Patients.

Who this might be right for
Oligometastatic Non-small Cell Lung Cancer (NSCLC)
Gustave Roussy, Cancer Campus, Grand Paris 124
Not applicableLooking for participantsNCT07441941
What this trial is testing

Single-Fraction Pulmonary Ablative Radiotherapy Outcomes and Quality-of-life Workup

Who this might be right for
Oligometastatic Lung TumorNSCLC (Non-small Cell Lung Cancer)SBRT
Institut du Cancer de Montpellier - Val d'Aurelle 190
Not applicableWithdrawnNCT01325753
What this trial is testing

Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body

Who this might be right for
Advanced Malignant MesotheliomaExtensive Stage Small Cell Lung CancerLung Metastases+4 more
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)UnknownNCT05472467
What this trial is testing

Camrelizumab Combination With SBRT and Concurrent Chemotherapy Treated Stage IV Oligometastatic Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Sichuan Cancer Hospital and Research Institute 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07777614
What this trial is testing

OPTIMISE Lung SABR

Who this might be right for
Non Small Cell Lung Cancer
Cancer Trials Ireland 208
Not applicableUnknownNCT03489616
What this trial is testing

Chemotherapy Combination With Local Radiotherapy and rhGM-CSF for Oligometastatic Stage IV NSCLC Patients

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Shandong Cancer Hospital and Institute 45
Testing effectiveness (Phase 2)UnknownNCT04306926
What this trial is testing

TQB2450 Injection Combined With Stereotactic Body Radiation Therapy (SBRT) in Subjects With Advanced Oligometastatic Non-Small Cell Lung Cancer

Who this might be right for
Advanced Oligometastatic Non-small Cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 59
Testing effectiveness (Phase 2)Looking for participantsNCT05501665
What this trial is testing

Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8Stage III Lung Cancer
Vanderbilt-Ingram Cancer Center 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT06219317
What this trial is testing

Immunotherapy Consolidation After Radical Treatment of Synchronous Oligo-metastatic NSCLC

Who this might be right for
NSCLC Stage IV
European Organisation for Research and Treatment of Cancer - EORTC 136
Next Page